川崎病，又称为皮肤黏膜淋巴结综合征，是一种全身急性血管炎性病变，属于自身免疫性疾病。目前，该疾病发病具体机制尚不明确，可能涉及核因子κB（nuclear factor-kappa B，NF-κB）信号通路参与的免疫反应、炎症反应、血管内皮损伤等诸多因素。尤其是川崎病合并心脏损伤患儿预后不佳，研究人员希望通过探索川崎病心脏损伤的具体发病机制，为临床诊断和治疗提供新的选择，并降低其发病率。该文就NF-κB信号通路在儿童川崎病心脏损伤中的机制进展做一综述，为后续研究提供理论指导。
Abstract
Kawasaki disease (KD), also known as mucocutaneous lymph node syndrome, is a systemic acute vasculitis belonging to autoimmune disease. Up to now, the specific pathogenesis of this disease remains unclear, and it may involve various factors such as immune response, inflammatory response, and vascular endothelial injury caused by the activation of the nuclear factor-kappa B (NF-κB) signaling pathway. In particular, children with KD and cardiac injury tend to have a poor prognosis, and researchers hope to explore the specific pathogenesis of cardiac injury in KD to provide new options for clinical diagnosis and treatment and reduce the incidence rate of this disorder. This article reviews the recent research on the role of the NF-κB signaling pathway in cardiac injury in children with KD, so as to provide a basis for future studies.
关键词
核因子-κB /
信号通路 /
川崎病 /
儿童
Key words
Nuclear factor-κB /
Signaling pathway /
Kawasaki disease /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Wang Y, Wang L, Wen X, et al. NF-κB signaling in skin aging[J]. Mech Ageing Dev, 2019, 184: 111160. PMID: 31634486. DOI: 10.1016/j.mad.2019.111160.
2 Lu X, Chen Q, Liu H, et al. Interplay between non-canonical NF-κB signaling and hepatitis B virus infection[J]. Front Immunol, 2021, 12:730684. PMID: 34659217. PMCID: PMC8511458. DOI: 10.3389/fimmu.2021.730684.
3 Krajka-Ku?niak V, Baer-Dubowska W. Modulation of Nrf2 and NF-κB signaling pathways by naturally occurring compounds in relation to cancer prevention and therapy. Are combinations better than single compounds?[J]. Int J Mol Sci, 2021, 22(15):8223. PMID: 34360990. PMCID: PMC8348704. DOI: 10.3390/ijms22158223.
4 Yu H, Lin L, Zhang Z, et al. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study[J]. Signal Transduct Target Ther, 2020, 5(1): 209. PMID: 32958760. PMCID: PMC7506548. DOI: 10.1038/s41392-020-00312-6.
5 Korbecki J, Simińska D, G?ssowska-Dobrowolska M, et al. Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-κB activation: a review of the molecular mechanisms[J]. Int J Mol Sci, 2021, 22(19): 10701. PMID: 34639040. PMCID: PMC8509318. DOI: 10.3390/ijms221910701.
6 B?ska P, Norbury LJ. The role of nuclear factor kappa B (NF-κB) in the immune response against parasites[J]. Pathogens, 2022, 11(3): 310. PMID: 35335634. PMCID: PMC8950322. DOI: 10.3390/pathogens11030310.
7 Yao C, Narumiya S. Prostaglandin-cytokine crosstalk in chronic inflammation[J]. Br J Pharmacol, 2019, 176(3): 337-354. PMID: 30381825. PMCID: PMC6329627. DOI: 10.1111/bph.14530.
8 Bartekova M, Radosinska J, Jelemensky M, et al. Role of cytokines and inflammation in heart function during health and disease[J]. Heart Fail Rev, 2018, 23(5): 733-758. PMID: 29862462. DOI: 10.1007/s10741-018-9716-x.
9 Ferrandino F, Grazioli P, Bellavia D, et al. Notch and NF-κB: coach and players of regulatory T-cell response in cancer[J]. Front Immunol, 2018, 9: 2165. PMID: 30364244. PMCID: PMC6193072. DOI: 10.3389/fimmu.2018.02165.
10 Barnabei L, Laplantine E, Mbongo W, et al. NF-κB: at the borders of autoimmunity and inflammation[J].Front Immunol, 2021, 12:716469. PMID: 34434197. PMCID: PMC8381650. DOI: 10.3389/fimmu.2021.716469.
11 Rife E, Gedalia A. Kawasaki disease: an update[J]. Curr Rheumatol Rep, 2020, 22(10): 75. PMID: 32924089. PMCID: PMC7487199. DOI: 10.1007/s11926-020-00941-4.
12 Zinatizadeh MR, Schock B, Chalbatani GM, et al. The nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases[J]. Genes Dis, 2021, 8(3): 287-297. PMID: 33997176. PMCID: PMC8093649. DOI: 10.1016/j.gendis.2020.06.005.
13 Armaroli G, Verweyen E, Pretzer C, et al. Monocyte-derived interleukin-1β as the driver of S100A12-induced sterile inflammatory activation of human coronary artery endothelial cells: implications for the pathogenesis of Kawasaki disease[J]. Arthritis Rheumatol, 2019, 71(5): 792-804. PMID: 30447136. DOI: 10.1002/art.40784.
14 Bassiouni W, Ali MAM, Schulz R. Multifunctional intracellular matrix metalloproteinases: implications in disease[J]. FEBS J, 2021, 288(24): 7162-7182. PMID: 33405316. DOI: 10.1111/febs.15701.
15 Stock AT, Jama HA, Hansen JA, et al. TNF and IL-1 play essential but temporally distinct roles in driving cardiac inflammation in a murine model of Kawasaki disease[J]. J Immunol, 2019, 202(11): 3151-3160. PMID: 30996002. DOI: 10.4049/jimmunol.1801593.
16 Tremoulet AH, Jain S, JonePN, et al. Phase I/IIatrial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm[J]. J Pediatr, 2019, 215:107-117.e12. PMID: 31561960. PMCID: PMC6878161. DOI: 10.1016/j.jpeds.2019.07.064.
17 Chen J, Jiang L, Yu XH, et al. Endocan: a key player of cardiovascular disease[J]. Front Cardiovasc Med, 2022, 8:798699. PMID: 35071362. PMCID: PMC8766991. DOI: 10.3389/fcvm.2021.798699.
18 Sakurai Y. Autoimmune aspects of Kawasaki disease[J]. J Investig Allergol Clin Immunol, 2019, 29(4): 251-261. PMID: 30183655. DOI: 10.18176/jiaci.0300.
PDF(461 KB)
